CoChat

Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression

Open access
Dudek, Katarzyna A., Dion-Albert, Laurence, Lebel, Manon, LeClair, Katherine, Labrecque, Simon, Tuck, Ellen, Ferrer Perez, Carmen, Golden, Sam A., Tamminga, Carol, Turecki, Gustavo, Mechawar, Naguib, Russo, Scott J., Menard, Caroline · 2020 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Significance: Thirty to fifty percent of depressed individuals are unresponsive to commonly prescribed antidepressant treatments, suggesting that biological mechanisms, such as stress-induced inflammation and blood vessel dysfunction, remain untreated. The blood–brain barrier is the ultimate frontier between the brain and harmful toxins or inflammatory signals circulating in the blood. Depression and vulnerability to chronic social stress are associated with loss of this barrier integrity; however, the mechanisms involved remain poorly understood. Identification of adaptations leading to resilience under stressful conditions could help develop novel treatments. Here we combined behavioral, pharmacological, and cell-specific gene profiling experiments in mice with epigenetic, molecular, and anatomical analysis of human samples to unravel mechanisms with therapeutic potential to protect the brain and promote resilience.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1914655117

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Permissive epigenetic regulation at the cldn5 promoter is associated with stress resilience. (A) Experimental timeline and (B) behavioral profile of unstressed CTRL, SS, SI ratio <1, and RES, SI ratio >1 (one-way ANOVA: F2,14 = 1,084; ***P < 0.0001, n = 10 to 12 mice/group). (C) Stress resilience is associated with higher permissive pan-acetylation on histone 3 (pan-acH3, two-way ANOVA: phenotype effect F2,168 = 168; ***P < 0.0001) and lower repressive methylation on H3K27me3 (two-way ANOVA: phenotype effect F2,168 = 32.05; ***P < 0.0001) on cldn5 gene promoter in the NAc of mice. Lower acetylation is also observed in SS mice when compared to CTRL (two-way ANOVA: phenotype effect F1,108 = 13.68; ***P = 0.0003). (D) Repressive histone methylation at CLDN5 promoter is reduced in the NAc of major depressive disorder (MDD) subjects under antidepressant (AD+) treatment at time of death when compared to healthy CTRL or MDD subjects without treatment (MDD, AD−) (500 bp, one-way ANOVA: F2,24 = 6.119; **P = 0.0071; 2,700 bp, one-way ANOVA: F2,24 = 4.513; *P = 0.0217; n = 5 to 15 subjects/group). If one- or two-way ANOVA statistical test was significant, Bonferroni posttests were performed with *P < 0.05; **P < 0.01; ***P < 0.001. See SI Appendix, Tables S1 and S3 for primers and detailed demographic data.
Fig. 1. Permissive epigenetic regulation at the cldn5 promoter is associated with stress resilience. (A) Experimental timeline and (B) behavioral profile of unstressed CTRL, SS, SI ratio <1, and RES, SI ratio >1 (one-way ANOVA: F2,14 = 1,084; ***P < 0.0001, n = 10 to 12 mice/group). (C) Stress resilience is associated with higher permissive pan-acetylation on histone 3 (pan-acH3, two-way ANOVA: phenotype effect F2,168 = 168; ***P < 0.0001) and lower repressive methylation on H3K27me3 (two-way ANOVA: phenotype effect F2,168 = 32.05; ***P < 0.0001) on cldn5 gene promoter in the NAc of mice. Lower acetylation is also observed in SS mice when compared to CTRL (two-way ANOVA: phenotype effect F1,108 = 13.68; ***P = 0.0003). (D) Repressive histone methylation at CLDN5 promoter is reduced in the NAc of major depressive disorder (MDD) subjects under antidepressant (AD+) treatment at time of death when compared to healthy CTRL or MDD subjects without treatment (MDD, AD−) (500 bp, one-way ANOVA: F2,24 = 6.119; **P = 0.0071; 2,700 bp, one-way ANOVA: F2,24 = 4.513; *P = 0.0217; n = 5 to 15 subjects/group). If one- or two-way ANOVA statistical test was significant, Bonferroni posttests were performed with *P < 0.05; **P < 0.01; ***P < 0.001. See SI Appendix, Tables S1 and S3 for primers and detailed demographic data.CC BY · PubMed Central
Fig. 2. Expression of repressive cldn5-related transcription factor FoxO1 is reduced in the endothelium of resilient mice. (A) Experimental timeline of a 10-d CSDS paradigm, SI test, and tissue collection for RNAscope in situ hybridization. (B) SI ratio of CTRL, SS, and RES mice (one-way ANOVA: F2,15 = 12.46; ***P = 0.0006, n = 6 mice/group). (C) Representative images of FoxO1 expression in the NAc which is reduced in RES mice (two-way ANOVA: phenotype × n clusters interaction effect F12,63 = 4.856; ***P < 0.0001, n = 2,306 to 3,657 cells from four mice/group) (Scale bar, 10 μm) (D). Nonendothelial cells are identified in light gray in the pie charts and endothelial cells, double labeled with CD31, split between shell (white for CTRL, dark gray for SS, pink for RES) and core (white for CTRL, black for SS, red for RES) subregions of the NAc. If one- or two-way ANOVA statistical test was significant, Bonferroni posttests were performed with *P < 0.05; **P < 0.01; ***P < 0.001.
Fig. 2. Expression of repressive cldn5-related transcription factor FoxO1 is reduced in the endothelium of resilient mice. (A) Experimental timeline of a 10-d CSDS paradigm, SI test, and tissue collection for RNAscope in situ hybridization. (B) SI ratio of CTRL, SS, and RES mice (one-way ANOVA: F2,15 = 12.46; ***P = 0.0006, n = 6 mice/group). (C) Representative images of FoxO1 expression in the NAc which is reduced in RES mice (two-way ANOVA: phenotype × n clusters interaction effect F12,63 = 4.856; ***P < 0.0001, n = 2,306 to 3,657 cells from four mice/group) (Scale bar, 10 μm) (D). Nonendothelial cells are identified in light gray in the pie charts and endothelial cells, double labeled with CD31, split between shell (white for CTRL, dark gray for SS, pink for RES) and core (white for CTRL, black for SS, red for RES) subregions of the NAc. If one- or two-way ANOVA statistical test was significant, Bonferroni posttests were performed with *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Fig. 3. Stress-induced transcriptome-wide changes in NAc endothelial cell gene expression. (A) Experimental timeline and (B) behavior profiles of CTRL, SS, and RES mice used to compare NAc endothelial cell gene expression (one-way ANOVA: F2,12 = 31.44; ***P < 0.0001, n = 4 to 6 mice/group). (C) Enrichment of NAc endothelial cells following MACS was confirmed by flow cytometry (C, 81.7% vs. 4.2% for heterogenous preparation including all cell types) and (D) quantitative PCR (500- to 12-fold enrichment for endothelial cell-related genes vs. 4- to 2-fold for astrocytes, 0.6-fold for oligodendrocytes, and 0.06-fold for neurons after MACS purification vs. heterogenous preparation). (E) Venn diagrams revealed poor overlap of gene expression changes when group comparisons were performed. Gene expression was mostly down-regulated (blue) in NAc endothelial cells of stressed mice when compared to unstressed controls with a similar number of genes being up-regulated (yellow) vs. down-regulated (blue) in RES vs. SS animals. Significance was set at ±2-fold change and P < 0.05. See Dataset S1 for detailed gene lists. (F) Hierarchical clustering heat map of SS vs. CTRL mice and biological pathways including the higher number of genes up-regulated (yellow) or down-regulated (blue) in the NAc endothelial cells of these groups of mice. One-way ANOVA statistical test was significant thus Bonferroni posttests were performed with ***P < 0.001.
Fig. 3. Stress-induced transcriptome-wide changes in NAc endothelial cell gene expression. (A) Experimental timeline and (B) behavior profiles of CTRL, SS, and RES mice used to compare NAc endothelial cell gene expression (one-way ANOVA: F2,12 = 31.44; ***P < 0.0001, n = 4 to 6 mice/group). (C) Enrichment of NAc endothelial cells following MACS was confirmed by flow cytometry (C, 81.7% vs. 4.2% for heterogenous preparation including all cell types) and (D) quantitative PCR (500- to 12-fold enrichment for endothelial cell-related genes vs. 4- to 2-fold for astrocytes, 0.6-fold for oligodendrocytes, and 0.06-fold for neurons after MACS purification vs. heterogenous preparation). (E) Venn diagrams revealed poor overlap of gene expression changes when group comparisons were performed. Gene expression was mostly down-regulated (blue) in NAc endothelial cells of stressed mice when compared to unstressed controls with a similar number of genes being up-regulated (yellow) vs. down-regulated (blue) in RES vs. SS animals. Significance was set at ±2-fold change and P < 0.05. See Dataset S1 for detailed gene lists. (F) Hierarchical clustering heat map of SS vs. CTRL mice and biological pathways including the higher number of genes up-regulated (yellow) or down-regulated (blue) in the NAc endothelial cells of these groups of mice. One-way ANOVA statistical test was significant thus Bonferroni posttests were performed with ***P < 0.001.CC BY · PubMed Central
Fig. 4. Inhibition of stress-induced increased hdac1 expression promotes resilience and rescues cldn5 expression. (A) Following 10 d of CSDS, hdac1 expression is down-regulated in the NAc endothelial cells of RES mice when compared to SS mice (one-way ANOVA, *P = 0.0301, n = 4 to 5 mice/group). (B and C) Higher stress-induced hdac1 level in the NAc of SS mice was confirmed by quantitative PCR and negatively correlated with SI (SI ratio: one-way ANOVA: F2,34 = 44.27; ***P < 0.0001; hdac1 fold change: one-way ANOVA: F2,29 = 6.122; **P = 0.0061, Pearson’s correlation between SI ratio and hdac1 fold change: **P = 0.0068, n = 10 to 16 mice/group). (D) Mice were screened with the SI test following 10 d of CSDS and split equally in two groups then administered vehicle or MS-275. (E) A second SI test was performed after 10 d of treatment revealing increased social interactions in the MS-275–treated group (unpaired t test: ***P < 0.0001) in line with higher cldn5 expression (Pearson’s correlation: **P = 0.0019, n = 11 mice/group). One-way ANOVAs statistical test were significant, thus Bonferroni posttests were performed with **P < 0.01; ***P < 0.001.
Fig. 4. Inhibition of stress-induced increased hdac1 expression promotes resilience and rescues cldn5 expression. (A) Following 10 d of CSDS, hdac1 expression is down-regulated in the NAc endothelial cells of RES mice when compared to SS mice (one-way ANOVA, *P = 0.0301, n = 4 to 5 mice/group). (B and C) Higher stress-induced hdac1 level in the NAc of SS mice was confirmed by quantitative PCR and negatively correlated with SI (SI ratio: one-way ANOVA: F2,34 = 44.27; ***P < 0.0001; hdac1 fold change: one-way ANOVA: F2,29 = 6.122; **P = 0.0061, Pearson’s correlation between SI ratio and hdac1 fold change: **P = 0.0068, n = 10 to 16 mice/group). (D) Mice were screened with the SI test following 10 d of CSDS and split equally in two groups then administered vehicle or MS-275. (E) A second SI test was performed after 10 d of treatment revealing increased social interactions in the MS-275–treated group (unpaired t test: ***P < 0.0001) in line with higher cldn5 expression (Pearson’s correlation: **P = 0.0019, n = 11 mice/group). One-way ANOVAs statistical test were significant, thus Bonferroni posttests were performed with **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Fig. 5. Increased HDAC1 expression is associated with CLDN5 loss in human depression. (A) FOXO1 expression is increased in the NAc of MDD patients with or without antidepressant treatment when compared to healthy controls (one-way ANOVA: F2,38 = 7.616; **P = 0.0017, 13 to 14 subjects/group). No change was observed for CTNNB1 (one-way ANOVA: F2,39 = 0.08791; P = 0.9160, n = 13 to 14 subjects/group). (B) HDAC1 expression is increased in the NAc of MDD patients without antidepressant treatment (one-way ANOVA: F2,36 = 3.865; *P = 0.0329) and correlated with CLDN5 mRNA level (Pearson’s correlation: *P = 0.0337, n = 12 to 14 subjects/group). (C) CLDN5 protein expression is reduced in postmortem NAc samples of depressed subjects when compared to healthy controls. (Scale bar, 100 μm.) See SI Appendix, Tables S1 and S3 for primers and detailed demographic data.
Fig. 5. Increased HDAC1 expression is associated with CLDN5 loss in human depression. (A) FOXO1 expression is increased in the NAc of MDD patients with or without antidepressant treatment when compared to healthy controls (one-way ANOVA: F2,38 = 7.616; **P = 0.0017, 13 to 14 subjects/group). No change was observed for CTNNB1 (one-way ANOVA: F2,39 = 0.08791; P = 0.9160, n = 13 to 14 subjects/group). (B) HDAC1 expression is increased in the NAc of MDD patients without antidepressant treatment (one-way ANOVA: F2,36 = 3.865; *P = 0.0329) and correlated with CLDN5 mRNA level (Pearson’s correlation: *P = 0.0337, n = 12 to 14 subjects/group). (C) CLDN5 protein expression is reduced in postmortem NAc samples of depressed subjects when compared to healthy controls. (Scale bar, 100 μm.) See SI Appendix, Tables S1 and S3 for primers and detailed demographic data.CC BY · PubMed Central
Fig. 6. Claudin5 (cldn5) permissive epigenetic regulation is associated with stress resilience while lack of endothelial molecular adaptations and inflammation leads to cldn5 loss and depression. Low hdac1 expression and high acetylation/low methylation on the cldn5 gene promoter allows maintenance of the BBB integrity under chronic stress leading to normal social and stress coping behaviors. These proresilient adaptive changes also include reduced expression of the repressive transcription factor Foxo1, possibly to prevent its binding to the cldn5 promoter now accessible through permissive epigenetic changes, and subsequent suppression of cldn5 production (Left). Conversely, endothelial inflammation mediated by high levels of circulating proinflammatory cytokines (7, 33), activation of TNFα/NFκB signaling, and elevated hdac1 activity prevents proper molecular adaptations, including access to the cldn5 gene promoter, leading to cldn5 loss. Stress-induced loss of this tight junction protein results in BBB hyperpermeability, passage of circulating proinflammatory mediators, and the establishment of depression-like behaviors (Right). Adapted with permission from ref. 7.
Fig. 6. Claudin5 (cldn5) permissive epigenetic regulation is associated with stress resilience while lack of endothelial molecular adaptations and inflammation leads to cldn5 loss and depression. Low hdac1 expression and high acetylation/low methylation on the cldn5 gene promoter allows maintenance of the BBB integrity under chronic stress leading to normal social and stress coping behaviors. These proresilient adaptive changes also include reduced expression of the repressive transcription factor Foxo1, possibly to prevent its binding to the cldn5 promoter now accessible through permissive epigenetic changes, and subsequent suppression of cldn5 production (Left). Conversely, endothelial inflammation mediated by high levels of circulating proinflammatory cytokines (7, 33), activation of TNFα/NFκB signaling, and elevated hdac1 activity prevents proper molecular adaptations, including access to the cldn5 gene promoter, leading to cldn5 loss. Stress-induced loss of this tight junction protein results in BBB hyperpermeability, passage of circulating proinflammatory mediators, and the establishment of depression-like behaviors (Right). Adapted with permission from ref. 7.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 361

Metadata

Authors
Dudek, K. A., Dion-Albert, L., Lebel, M., LeClair, K., Labrecque, S., Tuck, E., Ferrer Perez, C., Golden, S. A., Tamminga, C., Turecki, G., Mechawar, N., Russo, S. J., & Menard, C.
Affiliations
  • Université Laval (CA)
  • Department of Psychiatry and Neuroscience, Université Laval, Quebec City, QC G1V 0A6, Canada;
  • Icahn School of Medicine at Mount Sinai (US)
  • Centre de recherche CERVO (CA)
  • Trinity College Dublin (IE)
  • Center for Affective Neuroscience, Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029-5674;
  • University of Washington (US)
  • The University of Texas Southwestern Medical Center (US)
  • Douglas Mental Health University Institute (CA)
Venue
Proceedings of the National Academy of Sciences
Published
2020-01-23
Volume
117
Issue
6
Pages
3326-3336
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W3003128096
Cited by
361
References
53
Citations by year
2026: 51 · 2025: 73 · 2024: 55 · 2023: 53 · 2022: 55 · 2021: 50 · 2020: 22
FWCI
17.39
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Corpus Université Laval (Université Laval) (submittedVersion)
  • eScholarship@McGill (McGill) (submittedVersion, cc-by)
  • Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
Funders
  • Canada First Research Excellence Fund (Sentinel North Research Chair)
  • Brain and Behavior Research Foundation (24749)
  • Fonds de Recherche du Québec - Santé (265398)
  • Université Laval (Fondation Helene-Halle)
  • HHS | National Institutes of Health (R01 MH 104559, P50 MH 096890)
  • McGill University (Healty Brain, Healthy Lives)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
blood-brain barrier, stress resilience, depression, chronic social stress, neuroinflammation, antidepressant resistance, epigenetics, gene expression profiling
MeSH terms
Animals, Antidepressive Agents, Blood-Brain Barrier, Depression, Major Depressive Disorder, Disease Models, Animal, Humans, Inflammation, Male, Mice, Inbred C57BL, Nucleus Accumbens, Stress, Psychological, Signal Transduction, Epigenesis, Genetic, Mice, Histone Deacetylase 1, Claudin-5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression. https://app.cochat.ai/papers/10.1073/pnas.1914655117
The paper
Dudek, K. A., Dion-Albert, L., Lebel, M., LeClair, K., Labrecque, S., Tuck, E., Ferrer Perez, C., Golden, S. A., Tamminga, C., Turecki, G., Mechawar, N., Russo, S. J., & Menard, C. (2020). Molecular adaptations of the blood–brain barrier promote stress resilience vs. depression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1914655117

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.